A Corso, A Lorenzi, E Orlandi, C Astori, S Mangiacavalli, and M Lazzarino. 2002. “Advantages of Using Thalidomide for the Management of Refractory Myeloma Patients”. Haematologica 87 (3). Pavia, Italy, 327-28. https://doi.org/10.3324/%x.